# Dexlansoprazole

NDC: 62332-823
Generic name: Dexlansoprazole
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20251114

FDA application: ANDA219115

## Active ingredients

- DEXLANSOPRAZOLE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-823"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-823
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9607c88-03b7-46c6-8b88-84f01dcf2221